ABBV ▲ +0.0% - AbbVie Inc.
$ABBV - U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
28-SEP-2026 08:02 AM ET
Share this post
More filings for $ABBV
ABBV ▼ -0.2% - AbbVie Inc.Sep 22, 2026ABBV ▲ +0.5% - AbbVie Inc.Sep 22, 2026ABBV ▼ -0.7% - AbbVie Inc.Sep 21, 2026ABBV ▼ -0.1% - AbbVie Inc.Sep 18, 2026ABBV ▲ +0.0% - AbbVie Inc.Sep 15, 2026ABBV ▲ +0.9% - AbbVie Inc.Sep 10, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment